{"id":1228,"date":"2012-09-11T00:00:00","date_gmt":"2012-09-11T00:00:00","guid":{"rendered":"http:\/\/www.innovationanthology.com\/import\/2018\/02\/01\/innovation-anthology-495\/"},"modified":"2018-02-25T21:30:37","modified_gmt":"2018-02-25T21:30:37","slug":"innovation-anthology-495","status":"publish","type":"post","link":"https:\/\/www.innovationanthology.com\/import\/2012\/09\/11\/innovation-anthology-495\/","title":{"rendered":"Innovation Anthology #495:"},"content":{"rendered":"<p><a href=\"http:\/\/innovationanthology.com\/uploads\/Innovation Anthology 495.mp3\">Download MP3 Link<\/a><\/p>\n<p><b><br \/>\nDr. Michael Doschak\u2019s <\/b>success with a group of <b>biologics or peptide<\/b> compounds has opened the door to the commercialization of potential new treatments for <b>osteoporosis.  <\/b>\n <\/p>\n<p>\nThis pharmaceutical scientist is a member of Team Osteo Arthritis Alberta which is funded by Alberta Innovates Health Solutions.\n<\/p>\n<p>\nWorking with TEC Edmonton at the University of Alberta, Dr. Doschak\u2019s group has formed a spin-off company called<b> Osteo Metabolics.<\/b>\n<\/p>\n<p><b><br \/>\nDR. MICHAEL DOSCHAK:<\/b> <em>Again we were fortunate with our bone targeting calcitonin compound to get a patent filed on that in both the US and European markets as well as the Canadian market. So we do have intellectual property secured on this compound.   Our  planned delivery is  through trans-dermal micro-needle patches.  So you\u2019d put your patch on for osteo arthritis therapy and then take it off after an hour and maybe once a week.  Again these are a pipeline of bone targeting compounds and we have our head office here in Edmonton.<\/em>\n<\/p>\n<p>\nDr. Doschak says clinical trials for calcitonin will begin once his company Osteo Metabolics has secured a pharmaceutical partner.\n<\/p>\n<p><em><br \/>\nThanks today to <b>Alberta Innovates Health Solutions<\/em>\n<\/p>\n<p>\nFOR INNOVATION ANTHOLOGY<br \/>\nI\u2019M CHERYL CROUCHER<\/b>\n<\/p>\n<h2>Guest<\/h2>\n<h3> , <\/h3>\n<h4>, , , , <\/h4>\n<h2>Sponsor<\/h2>\n<h3><a href=\"http:\/\/www.aihealthsolutions.ca\">Alberta Innovates Health Solutions<\/a><\/h3>\n<p><font size=\"3\"><span style=\"font-weight: bold;\">Alberta Innovates (formerly Alberta Innovates &ndash; Health Solutions) <\/span><\/font><\/p>\n<p>As the newly formed Alberta Innovates corporation, we still fund top  quality, internationally competitive health&nbsp;research and innovation  activities to improve the health and wellbeing of Albertans.&nbsp;We provide  leadership for Alberta&rsquo;s health research and&nbsp;innovation enterprise by  directing, coordinating, reviewing, funding and supporting&nbsp;research and  innovation.<\/p>\n<p>Working&nbsp;with our many partners&nbsp; in the health system, we ensure that research achieves innovation  in&nbsp;care, policy and practice, and that the needs of patients and  clinicians influence&nbsp;research.<\/p>\n<h3>Our&nbsp;background<\/h3>\n<p><a href=\"http:\/\/albertainnovates.ca\/\" target=\"_blank\">Alberta Innovates<\/a> consolidation was launched November 1, 2016.<\/p>\n<p><strong>Alberta Innovates &ndash; Health Solutions<\/strong><\/p>\n<p>Alberta Innovates &ndash; Health Solutions was established as part of the Alberta Innovates system by an Act of Legislation of the Government of Alberta. It is a agency&nbsp;  of the Government of Alberta.&nbsp;We receive a yearly allocation from the  Ministry of Health and report through the ministry to the people of  Alberta.<\/p>\n<p>Our Mandate and Roles document reflects our role and responsibilities and outlines the government statues and regulations with which we comply.<\/p>\n<p>Alberta&rsquo;s Health Research and Innovation Strategy (AHRIS) sets out  Alberta&rsquo;s health research agenda for the coming decade to ensure our  considerable investments in research align with our priority&mdash;to improve  the health of Albertans.<\/p>\n<p>&nbsp;<\/p>\n<div class=\"et_pb_module et-waypoint et_pb_image et_pb_animation_off et_pb_image_3 et_always_center_on_mobile et_pb_image_sticky et-animated\"> \t\t\t\t<img decoding=\"async\" alt=\"\" src=\"http:\/\/albertainnovates.ca\/wp-content\/uploads\/2016\/10\/health_solutions_v2_icon.png\" \/> \t\t\t \t\t\t<\/div>\n<div class=\"et_pb_text et_pb_module et_pb_bg_layout_light et_pb_text_align_left  et_pb_text_2\">\n<p><strong>780-423-5727<br \/>Toll free: 1-877-423-5727<br \/><a href=\"http:\/\/aihealthsolutions.ca\">aihealthsolutions.ca<\/a><\/strong><\/p>\n<p>1500,<br \/>10104 &ndash; 103 Avenue<br \/>Edmonton, Alberta, Canada<br \/>T5J 4A7<\/p>\n<\/div>\n<p><img decoding=\"async\" src=\"http:\/\/innovationanthology.com\/uploads\/AI Health_AHFMR Tagline_RGB.jpg\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Program Date:<\/strong>\u00a02012-09-11<\/p>\n","protected":false},"excerpt":{"rendered":"<p><b>Dr. Michael Doschak\u2019s<\/b> success with a group of biologics or peptide compounds has opened the door to the commercialization of potential new treatments for <b>osteoporosis.<\/b>     Working with <b>TEC Edmonton <\/b>at the University of Alberta, Dr. Doschak\u2019s group has formed a spin-off company called <b>Osteo Metabolics. <\/b><em>(Alberta Innovates Health Solutions)<\/em><\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55,2],"tags":[],"class_list":["post-1228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alberta-innovates-health-solutions","category-health-and-medicine","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"jetpack_featured_media_url":"https:\/\/www.innovationanthology.com\/import\/wp-content\/uploads\/2018\/02\/495Michael_Doschak.jpg","_links":{"self":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/1228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/comments?post=1228"}],"version-history":[{"count":3,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/1228\/revisions"}],"predecessor-version":[{"id":4814,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/1228\/revisions\/4814"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/media?parent=1228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/categories?post=1228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/tags?post=1228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}